-
Mashup Score: 0Amylyx ALS Candidate Denied in Painfully Close AdCom Vote - 2 year(s) ago
From left: Amylyx Co-founders and Co-CEOs Justin Klee and Josh Cohen/Courtesy Amylyx
Source: PharmaLiveCategories: Latest Headlines, Rare DiseaseTweet
-
Mashup Score: 3Highlights from American Society of Hematology 2021 Meeting - 2 year(s) ago
Source: BioSpace
Source: PharmaLiveCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @cotahealthcare: What were the highlights from #ASH21? @biospace shares their take here: https://t.co/akFj3mZgIo #oncology #hematology #…
-
-
Mashup Score: 0FDA Rejects Orphazyme’s Genetic Disease Drug - 3 year(s) ago
Source: BioSpace
Source: PharmaLiveCategories: Latest Headlines, Rare DiseaseTweet-
FDA Rejects Orphazyme’s Genetic Disease Drug https://t.co/HqaNEsV7Hy
-
-
Mashup Score: 15Med Ad News Announces 2021 Manny Awards Finalists and Klick Health's Lori Grant as Industry Person of the Year - 3 year(s) ago
Leading pharmaceutical business and marketing publication Med Ad News announces the nominees for the 32nd Annual Manny Awards, recognizing the best in healthcare advertising and communications. The 2021 Manny Awards ceremony will be held virtually on Thursday, April 22. Klick Health CEO Lori Grant i
Source: PharmaLiveCategories: Future of Medicine, Latest HeadlinesTweet-
Med Ad News Announces 2021 Manny Awards Finalists and Klick Health’s Lori Grant as Industry Person of the Year https://t.co/MtalimdVIf #digitalhealth @klickhealth
-
-
Mashup Score: 1Johns Hopkins Scientists Discover Possible Key to Controlling Covid-19 Immune Response - 4 year(s) ago
Researchers at Johns Hopkins Medicine identified a protein – known as factor D – that appears essential to the inflammatory process of SARS-CoV-2, the virus that causes Covid-19.
Source: PharmaLiveCategories: Healthcare Professionals, Latest HeadlinesTweet-
RT @PamelaJohnsonMD: https://t.co/3Jyt29Hyht @BloodJournal @HopkinsMedicine https://t.co/aBF937te5C
-
-
Mashup Score: 5Bristol Myers Squibb’s Opdivo Hits Mark in Two Phase III Studies - 4 year(s) ago
Bristol Myers Squibb announced positive data from two separate Phase III clinical trials of the company’s checkpoint inhibitor Opdivo (nivolumab).
Source: PharmaLiveCategories: Hem/Oncs, Latest HeadlinesTweet-
The RECOVERY trial was never medicine by press release (The un-redacted protocol and statistical analysis plan were available) This is medicine by press release https://t.co/Sa1Cgd5sA6
-
-
Mashup Score: 0
Startup IgGenix Inc. emerged from stealth mode with $10 million in Series A financing and a goal to advance the company’s novel antibody therapeutics platform for the treatment of food and non-food allergies, as well as other severe allergic conditions.
Source: PharmaLiveCategories: Healthcare Professionals, Latest HeadlinesTweet-
IgGenix Launches with $10 Million to Develop Therapeutics for Severe Allergies https://t.co/cV3YveB38Y
-
-
Mashup Score: 22
The European Union is planning to leverage an emergency fund worth $2.7 billion to buy promising COVID-19 vaccines ahead of approval.
Source: PharmaLiveCategories: Healthcare Professionals, Latest HeadlinesTweet-
@gavi This should make headlines. But looking at Google News right now I only two articles. One by 'Pharma Live’ https://t.co/clOmas2UpA and in mainstream media outlets only this two paragraph article in Reuters https://t.co/gYwNk29PDl https://t.co/bBwBlJRPVN
-
-
Mashup Score: 0Post COVID-19: Telemedicine is the new Urgent Care - 4 year(s) ago
The COVID-19 global pandemic, overcrowding of hospitals, the highly contagious virus affecting healthcare professionals and unrelated illnesses has led to a more than 1,000 percent increase of telemed application downloads and memberships. Is this a paradigm shift?
Source: PharmaLiveCategories: Healthcare Professionals, Latest HeadlinesTweet-
Post COVID-19: Telemedicine is the new Urgent Care https://t.co/yTetpq6FAv . . . #telehealth #telemedicine #virtualcare #healthcare
-
-
Mashup Score: 0How NLP Will Contribute to the Future of Drug Safety - 4 year(s) ago
The recent 20th anniversary of the groundbreaking “To Err is Human” report that launched the modern patient safety movement is cause for reflection on the healthcare industry’s past and future efforts to reduce medical errors and preventable deaths.
Source: PharmaLiveCategories: Healthcare ProfessionalsTweet-
How #NLP Will Contribute to the Future of #Drug Safety | #AI #pharma - by @Linguamatics https://t.co/pafZftBSvi
-
Amylyx ALS Candidate Denied in Painfully Close AdCom Vote https://t.co/NT2Xlhv0j6